Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACRS Aclaris Therapeutics

休市中 08-23 16:00:00 EDT

1.21

+0.01

+0.83%

盘后1.22

+0.01+0.83%

17:20 EDT

最高1.23	最低1.20	成交量11.59万
今开1.23	昨收1.20	日振幅2.50%
总市值8,633万	流通市值6,681万	总股本7,134万
成交额14.05万	换手率0.21%	流通股本5,522万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACRS","market":"US","secType":"STK","nameCN":"Aclaris Therapeutics","latestPrice":1.21,"timestamp":1724443200000,"preClose":1.2,"halted":0,"volume":115925,"hourTrading":{"tag":"盘后","latestPrice":1.22,"preClose":1.21,"latestTime":"17:20 EDT","volume":407,"amount":496.4202,"timestamp":1724448055418},"delay":0,"floatShares":55215949,"shares":71344557,"eps":-0.828729,"marketStatus":"休市中","marketStatusCode":7,"change":0.01,"latestTime":"08-23 16:00:00 EDT","open":1.23,"high":1.23,"low":1.2,"amount":140533.3155575,"amplitude":0.025,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.828729,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":1444190400000,"adjPreClose":1.2,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.24,"preClose":1.2,"latestTime":"08:49 EDT","volume":25,"amount":31,"timestamp":1724417341283},"postHourTrading":{"tag":"盘后","latestPrice":1.22,"preClose":1.21,"latestTime":"17:20 EDT","volume":407,"amount":496.4202,"timestamp":1724448055418},"volumeRatio":0.45579290458192245,"impliedVol":4.1152,"impliedVolPercentile":0.9881},"requestUrl":"/m/hq/s/ACRS/tweets","defaultTab":"tweets","newsList":[{"id":"2460053247","title":"Aclaris Therapeutics, Inc.盘中异动 大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460053247","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460053247?lang=zh_cn&edition=full","pubTime":"2024-08-19 22:49","pubTimestamp":1724078958,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日22时49分，Aclaris Therapeutics, Inc.股票出现异动，股价快速拉升5.00%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体涨幅为0.35%。其相关个股中，Applied Dna Sciences, Inc.、Ispecimen Inc.、Prophase Labs, Inc.涨幅较大，Applied Dna Sciences, Inc.、Ispecimen Inc.、Endra Life Sciences Inc.较为活跃，换手率分别为1200.82%、15.69%、12.10%，振幅较大的相关个股有Applied Dna Sciences, Inc.、Bioaffinity Technologies Inc C/Wts 07/09/2027 、Prenetics Global，振幅分别为121.98%、92.50%、25.00%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819224919ab5e6e20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240819224919ab5e6e20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRS","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2460321241","title":"Aclaris Therapeutics, Inc.2024财年第二财季实现净利润-10.99百万美元，同比增加62.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460321241","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460321241?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824036,"startTime":"0","endTime":"0","summary":"8月17日，Aclaris Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-10.99百万美元，同比增加62.83%；其中营业收入为2.77百万美元，同比增加48.13%，每股基本收益为-0.15美元。从资产负债表来看，Aclaris Therapeutics, Inc.总负债27.25百万美元，其中短期债务449000.00美元，资产负债比为0.06，流动比率为0.08。机构评级：截至2024年8月17日，当前有4家机构对Aclaris Therapeutics, Inc.目标价做出预测，其中目标均价为2.05美元，其中最低目标价为1.20美元，最高目标价为3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170005559f31b10c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170005559f31b10c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ACRS"],"gpt_icon":0},{"id":"2459272824","title":"Aclaris Therapeutics, Inc.盘中异动 大幅拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459272824","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459272824?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:32","pubTimestamp":1723728733,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时32分，Aclaris Therapeutics, Inc.股票出现异动，股价快速拉升5.13%。截至发稿，该股报1.23美元/股，成交量5.1105万股，换手率0.07%，振幅0.00%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体涨幅为0.53%。其相关个股中，Aclaris Therapeutics, Inc.、Veracyte, Inc.、Exagen Inc.涨幅较大，Applied Dna Sciences, Inc.、Endra Life Sciences Inc.、Psychemedics Corporation较为活跃，换手率分别为14.69%、1.28%、0.48%，振幅较大的相关个股有Applied Dna Sciences, Inc.、Neuronetics, Inc.、Personalis, Inc.，振幅分别为7.59%、5.65%、4.69%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213213959b9fdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213213959b9fdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","ACRS"],"gpt_icon":0},{"id":"2459180595","title":"Aclaris Therapeutics, Inc.盘中异动 急速拉升5.26%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459180595","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459180595?lang=zh_cn&edition=full","pubTime":"2024-08-14 01:44","pubTimestamp":1723571071,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日01时44分，Aclaris Therapeutics, Inc.股票出现异动，股价急速上涨5.26%。截至发稿，该股报1.20美元/股，成交量26.6943万股，换手率0.37%，振幅5.70%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体涨幅为1.01%。其相关个股中，Psychemedics Corporation、Personalis, Inc.、Veracyte, Inc.涨幅较大，Endra Life Sciences Inc.、Psychemedics Corporation、Neuronetics, Inc.较为活跃，换手率分别为8.01%、6.84%、3.63%，振幅较大的相关个股有Personalis, Inc.、Exagen Inc.、安奈特保险，振幅分别为21.58%、17.61%、15.77%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814014431ab5d9cc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814014431ab5d9cc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","ACRS","LENZ"],"gpt_icon":0},{"id":"2456587602","title":"Aclaris Therapeutics Inc    预计每股亏损 20 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456587602","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456587602?lang=zh_cn&edition=full","pubTime":"2024-08-03 01:31","pubTimestamp":1722619878,"startTime":"0","endTime":"0","summary":"   * Aclaris Therapeutics Inc    预计将在8月5日公布截至2024年6月30日的业绩报告() 时显示季度收入下降。* 根据LSEG的数据，9位分析师的平均预期显示，这家总部位于宾夕法尼亚州韦恩市的公司预计营收将从去年同期的187万美元下降2.8%，至181.8万美元。* LSEG 分析师对 Aclaris Therapeutics Inc 的平均预期是每股亏损 20 美分。* 华尔街对 Aclaris Therapeutics Inc 的 12 个月目标价中位数为 2.00 美元，高于其上一次收盘价 1.32 美元。8月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ACRS"],"gpt_icon":0},{"id":"2453006289","title":"Aclaris Therapeutics, Inc.盘中异动 临近收盘股价大涨5.26%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453006289","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453006289?lang=zh_cn&edition=full","pubTime":"2024-07-24 03:51","pubTimestamp":1721764310,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日03时51分，Aclaris Therapeutics, Inc.股票出现波动，股价快速上涨5.26%。截至发稿，该股报1.40美元/股，成交量57.3356万股，换手率0.80%，振幅3.38%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体涨幅为0.37%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724035150af93b307&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724035150af93b307&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","ACRS"],"gpt_icon":0},{"id":"2453793054","title":"Aclaris Therapeutics, Inc.盘中异动 早盘股价大涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453793054","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453793054?lang=zh_cn&edition=full","pubTime":"2024-07-22 21:54","pubTimestamp":1721656496,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日21时54分，Aclaris Therapeutics, Inc.股票出现异动，股价大幅拉升5.49%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体涨幅为1.58%。其相关个股中，Star Equity Holdings Inc Cum Perpetual Pfd Ser A、Bioaffinity Technologies, Inc.、Aclaris Therapeutics, Inc.涨幅较大，Personalis, Inc.、Ispecimen Inc.、Endra Life Sciences Inc.较为活跃，换手率分别为2.31%、1.36%、0.94%，振幅较大的相关个股有T2 Biosystems, Inc.、Mainz Biomed N.V.、Personalis, Inc.，振幅分别为10.45%、9.74%、8.05%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222154569681ee72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222154569681ee72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ACRS","BK4139","LENZ"],"gpt_icon":0},{"id":"2452840139","title":"Aclaris Therapeutics(ACRS)盘前涨超10% 出售OLUMIANt专利权","url":"https://stock-news.laohu8.com/highlight/detail?id=2452840139","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452840139?lang=zh_cn&edition=full","pubTime":"2024-07-17 18:03","pubTimestamp":1721210594,"startTime":"0","endTime":"0","summary":"金吾财讯 | Aclaris Therapeutics(ACRS)盘前涨超10%，截至发稿，报1.48美元。消息面上，aclaris therapeutics宣布向omers life sciences出售OLUMIANt专利权和里程碑，最高可达3150万美元。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210625/NWUyOTcwN2U1MzQ2YjViNjMyZDcwZGM2MmQ0YzE5MjMxNzMwNDc5NDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NWUyOTcwN2U1MzQ2YjViNjMyZDcwZGM2MmQ0YzE5MjMxNzMwNDc5NDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"277875","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4007","BK4139","ACRS"],"gpt_icon":0},{"id":"2446341944","title":"成分股Lyell Immunopharma收跌36.03%，该公司针对三阴性乳腺癌疗法ROR1 CAR-T候选药LYL979的早期临床试验中，一名病患死亡；","url":"https://stock-news.laohu8.com/highlight/detail?id=2446341944","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446341944?lang=zh_cn&edition=full","pubTime":"2024-06-27 05:51","pubTimestamp":1719438669,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["LENZ","SIGA","ACRS","MRNA","BK1576","BK4022","BK1141","BK4533","CAR","BK4548","BK4007","BK4551","BK4539","BK4532","BK4230","ERAS","BK1583","BK4139","BK4505","BK4534","03347","BK4501","BK4583","BK4585","BMEA","LYEL","BK4588","BK4568"],"gpt_icon":0},{"id":"2446881074","title":"成分股阿里拉姆制药（ALNY）收涨34.52%，bluebird bio涨13.45%，Aclaris Therapeutics涨12.","url":"https://stock-news.laohu8.com/highlight/detail?id=2446881074","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446881074?lang=zh_cn&edition=full","pubTime":"2024-06-25 04:51","pubTimestamp":1719262291,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4139","BK4588","ACRS","BK4548","LENZ","BK4007","BK4585","BK1574","01477","BK1191","ALNY"],"gpt_icon":0},{"id":"2433723441","title":"BUZZ-Aclaris Therapeutics 因第一季度收入下降而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2433723441","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433723441?lang=zh_cn&edition=full","pubTime":"2024-05-08 20:46","pubTimestamp":1715172412,"startTime":"0","endTime":"0","summary":"    5月8日 - ** 药物开发商 Aclaris Therapeutics    股价盘前下跌 5.9% 至 1.26 美元 ** 该公司周二晚些时候公布的第一季度收入为240万美元，去年同期为253万美元 ** 截至 2024 年 3 月 31 日，公司拥有现金、现金等价物和有价证券 1.614 亿美元，而截至 2023 年 12 月 31 日为 1.819 亿美元。** 公司表示，第一季度的大部分现金支出与终止研发项目和之前宣布的裁员有关， 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LENZ","BK4139","BUZZ","ACRS"],"gpt_icon":0},{"id":"2433675883","title":"Aclaris Therapeutics Inc 报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2433675883","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433675883?lang=zh_cn&edition=full","pubTime":"2024-05-08 05:02","pubTimestamp":1715115778,"startTime":"0","endTime":"0","summary":"   * Aclaris Therapeutics Inc   报告，截至1月底的季度调整后每股亏损24美分，高于去年同期的每股-40美分。八位分析师对该季度的平均预期是每股亏损 29 美分。华尔街预期为每股-37美分至-8美分。* 营收为 240 万美元，同比下降 5.1%；分析师预期为 137 万美元。* Aclaris Therapeutics Inc公布的本季度每股收益为亏损24美分。* 该公司当季亏损 1694 万美元。* Aclaris Therapeutics Inc的股价本季度上涨了5.6%，今年迄今为止上涨了24.8%。* 华尔街对 Aclaris Therapeutics Inc 的 12 个月目标价中位数为 2.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRS","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2432157843","title":"Aclaris Therapeutics Inc    预计每股亏损 29 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432157843","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432157843?lang=zh_cn&edition=full","pubTime":"2024-05-04 08:18","pubTimestamp":1714781891,"startTime":"0","endTime":"0","summary":"   * Aclaris Therapeutics Inc    将于5月7日公布截至2024年3月31日的季度业绩报告，预计该公司的季度收入将出现下降。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于宾夕法尼亚州韦恩市的公司预计营收将从去年同期的253万美元下降45.9%，至136.7万美元。* LSEG 分析师对 Aclaris Therapeutics Inc 的平均预期是每股亏损 29 美分。* 华尔街对 Aclaris Therapeutics Inc 的 12 个月目标价中位数为 2.00 美元，高于其上次收盘价 1.36 美元。5月4日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","ACRS"],"gpt_icon":0},{"id":"2419600384","title":"纳斯达克生物科技指数跌1.6%，成分股和黄医药ADR（HCM）跌9.21%目前表现最差，据媒体报道，该公司向苏慰国授出合共135.","url":"https://stock-news.laohu8.com/highlight/detail?id=2419600384","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2419600384?lang=zh_cn&edition=full","pubTime":"2024-03-14 22:14","pubTimestamp":1710425648,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["TQQQ","BK4139",".IXIC","PSQ","GRFS","BK1587","SQQQ","BK1191","BK1147","159837","SA","BK4583","BK4017","QLD","159632","ARTL","ACRS","BK1588","BK4007","03086","QID","BK4585","QQQ","BK4531","SIGA","HCM","00013","NDX","BK4505","BK4588","AKRO","NQmain","MNQmain"],"gpt_icon":0},{"id":"2414708958","title":"Aclaris Therapeutics(ACRS.US)：2023年Q4财报实现营收1757万美元，前值为775.3万美元，预期值为336万美元；","url":"https://stock-news.laohu8.com/highlight/detail?id=2414708958","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2414708958?lang=zh_cn&edition=full","pubTime":"2024-02-27 21:54","pubTimestamp":1709042051,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","ACRS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aclaristx.com","stockEarnings":[{"period":"1week","weight":0.0168},{"period":"1month","weight":-0.1232},{"period":"3month","weight":0.0901},{"period":"6month","weight":0.0168},{"period":"1year","weight":-0.8274},{"period":"ytd","weight":0.1524}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aclaris Therapeutics, Inc.于2012年7月在美国特拉华州成立。该公司是一家临床阶段的生物制药公司，专注于开发免疫炎症疾病的新型候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.159429},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.00511},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.035243},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.000298},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.054521},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.002463},{"month":7,"riseRate":0.555556,"avgChangeRate":0.002503},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.048357},{"month":9,"riseRate":0.5,"avgChangeRate":0.038413},{"month":10,"riseRate":0.25,"avgChangeRate":0.052818},{"month":11,"riseRate":0.222222,"avgChangeRate":-0.060376},{"month":12,"riseRate":0.777778,"avgChangeRate":0.149317}],"exchange":"NASDAQ","name":"Aclaris Therapeutics","nameEN":"Aclaris Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aclaris Therapeutics(ACRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aclaris Therapeutics,ACRS,Aclaris Therapeutics股票,Aclaris Therapeutics股票老虎,Aclaris Therapeutics股票老虎国际,Aclaris Therapeutics行情,Aclaris Therapeutics股票行情,Aclaris Therapeutics股价,Aclaris Therapeutics股市,Aclaris Therapeutics股票价格,Aclaris Therapeutics股票交易,Aclaris Therapeutics股票购买,Aclaris Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aclaris Therapeutics(ACRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}